Program Overview

The first years of a child’s life are a time of rapid development. It is important to identify conditions that could adversely affect development as early as possible. The New York State Department of Health (NYSDOH) recognizes the importance of preventive care during this period in the Medicaid and Child Health Plus (CHP) pediatric populations. That recognition is the foundation for the Kids Quality Agenda Performance Improvement Project (PIP). This PIP incorporates three focus areas:

  • Blood lead testing and follow-up
  • Newborn hearing screening and follow-up
  • Developmental screening

 

  • Blood Lead Testing and Follow-up

    Medicaid Blood Lead Testing Guidelines

    The Centers for Medicare & Medicaid Services (CMS) require that all children enrolled in Medicaid receive blood lead testing at ages 12 months and 24 months. Also, Medicaid-enrolled children older than 24 months but younger than 72 months without a blood lead test on record must receive one. Completion of a lead risk assessment questionnaire does not satisfy this requirement [CMS, 2016]. In addition, NYS law mandates that all children receive blood lead tests twice prior to turning three years old, once around age one and again around age two [NYS, 2009].

    Updates to Definition of an Elevated Blood Lead Level (BLL)

    The NYS Public Health Laws were recently amended to lower the definition of an elevated BLL in a child to 5 micrograms per deciliter (ug/dl), previously 10 ug/dl, effective on October 1, 2019.

    Guidelines

    • Children should receive a blood lead test around age one
    • Children should also receive a blood lead test around age two
    • Children who have a capillary BLL ≥5mcg/dl should have a confirmatory venous test within three months
    • Children who have a confirmed venous BLL ≥5mcg/dl should have a follow-up venous blood lead test within three months

    Additional training material including Managing Blood Lead and self-guided NYSIIS training videos can be accessed by Signing In to the Health Commerce System.


  • Newborn Hearing Screening and Follow-up

    The National Center for Hearing Assessment and Management (NCHAM) estimates three out of every 1,000 newborns in the US have permanent hearing loss. If hearing loss is undetected, it can lead to delayed speech, language, social, and emotional development. It is critical that providers review the results of every newborn hearing test conducted, including at the birthing facility, to ensure newborns who did not pass their initial screening have a follow-up or diagnostic audiological exam.

    Guidelines

    • Newborns should have a hearing screening by one month of age
    • Pediatricians should confirm the results of all their patients’ newborn hearing screenings at their initial visit
    • Diagnostic audiological evaluation should be performed by three months of age if the newborn did not pass the initial hearing screening
    • Newborns diagnosed with hearing loss should be referred to Early Intervention (EI) services by six months of age


  • Developmental Screening

    Evidence suggests that many children are not identified with developmental delays until they begin school. Children insured by Medicaid are twice as likely to be at risk for developmental delays. Other risk factors include pre-term birth, low birth weight, and prenatal alcohol or drug exposure.

    The American Academy of Pediatrics (AAP) recommends routine screening with a standardized developmental screening tool at nine, 18, and 30 months to identify areas of a child’s development that differ from age-specific norms.

    Developmental surveillance should also be completed at every provider visit to monitor children who may be at risk for developmental delays.

    Best Practices for Developmental Screening

    Use of Evidence-Based Developmental Screening Tools

    Evidence-based developmental screening tools, such as the Ages & Stages Questionnaires® (ASQ), provide reliable, accurate developmental and social-emotional screening for children. If the parent or guardian can complete the screening tool prior to the appointment then more time can be spent on discussing the responses and reviewing a development plan, if needed. Implement office procedures that allows for the screening tool to be completed prior to the scheduled appointment, such as:

    • Mail a paper copy of the screening to the member’s parent or guardian so that it can be completed prior to the scheduled appointment
    • When confirming the appointment via email, phone, or patient portal, provide a link to complete an online version of the screening tool
    • For those that do not complete the paper or online screening tool ahead of the scheduled appointment, provide them with a tablet or paper form to fill out while in the waiting room

    Find additional developmental screening tools and other resources recommended by the AAP to support effective management of early childhood development.

    Pre-visit Planning

    Coordinate with social workers or case managers to call ahead to remind the family about the scheduled appointment, assist with any transportation or other needs, and then conduct brief screenings, including a developmental screening.

    In-office Screening Process Workflow

    Create a screening process workflow that works best for all staff within the office for all screenings, or for those patients who did not return a completed screening form to the appointment. Each provider office is unique, there isn’t a “one size fits all” process, but the following tools are available to help establish a screening process workflow that will work best for your practice:

    AAP – Getting Started: Implementing a Screening Process

    AAP – Improving Developmental Screening and Follow-up: Comprehensive Quality Improvement Toolkit

    Autism Screening

    The prevalence of autism spectrum disorders (ASDs) in 11 surveillance states was 2 in 59 children aged 8 years in 2014. (Baio, MMWR 2018; AAP 2007)

    The AAP recommends formal autism screening with a validated autism-specific tool at 18 and 24 months to monitor for developmental regression.

    Developmental and Autism Specific Screening Coding

    To effectively track global developmental and autism-specific screenings, NYS requests that providers bill to the following CPT codes:

    • 96110 code for global developmental screening with a standardized screening tool
    • 96110 with CG modifier for autism-specific screening with a standardized screening tool


Additional Resources

AAP Developmental Screening

Health Commerce System

Medicaid Lead Screening Guidelines

National Center for Hearing Assessment and Management

NYS Early Hearing Detection and Intervention Program

NYS Lead Poisoning Prevention and Management